sr 95531 has been researched along with am 281 in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (am 281) | Trials (am 281) | Recent Studies (post-2010) (am 281) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 104 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, GZ; Woolley, CS | 1 |
1 other study(ies) available for sr 95531 and am 281
| Article | Year |
|---|---|
Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism.
Topics: Animals; Benzodioxoles; Benzoxazines; Biophysics; CA1 Region, Hippocampal; Cannabinoid Receptor Modulators; Castration; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Estradiol; Estrogens; Excitatory Amino Acid Agents; Female; GABA Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Lactones; Male; Morpholines; NAD; Naphthalenes; Neural Inhibition; Neurons; Orlistat; Patch-Clamp Techniques; Phenols; Piperidines; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 2012 |